Pricing

Atalanta Therapeutics

1 follower

‌

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.

Industries

Biotechnology, Education

Headquarters

Boston, United States

Employees

11-50

Links

Org chart

Alicia Secor

President & CEO

Alicia Secor

Collapse

Aimee L. Jackson

Chief Scientific Officer

Morgan Molloy

Chief Corporate Development Officer

Bart G. Newland

General Counsel

Michele Keough

SVP, Program & Alliance Management

Stephen Burke

SVP, Human Resources

Brittany Ferdman

Purchasing Coordinator

Anastasia Khvorova

Co-founder

Craig Mello

Co-founder

Jeff Young

Chief Financial Officer

Serena Hung

Chief Medical Officer

Antonio N.

Sr. Director Information Technology

Rachael Johnson

Executive Assistant

Board & advisors

Neil Aronin

Co-founder & Scientific Advisor

Anastasia Khvorova

Co-founder & Scientific Advisor

Craig Mello

Co-founder & Scientific Advisor

Co-founder

Director

Director

Director

Director

Director

Teams

Scientific Research Team

11 members

Scientific and Technical Advisory

10 members

Leadership Team

7 members

Operations Team

4 members

Research and Development

5 members

Offices

Similar companies

Tessera Therapeutics

2 followers

Pyxis Oncology

2 followers

Brightseed

2 followers

Obsidian Therapeutics

1 follower

Apogee Therapeutics

1 follower

Cargo

1 follower

Cue Biopharma

1 follower

Anthos Therapeutics

1 follower

Kyverna Therapeutics

7 followers

Generate Biomedicines

3 followers

Strand Therapeutics

3 followers

Explore companies